New York, USA — 16 February 2018 — Real Life Sciences releases an innovative new technology targeted at helping apply automation to the Clinical Trial Disclosure process. The software is end-to-end, providing Risk Assessment, Redaction, and Anonymization all-in-one place, making the process ... Read more